bf/NYSE:NVO_icon.jpeg

NYSE:NVO

Novo Nordisk A/S

  • Stock

65.60

−1.28%

−6.10

USD last updated 27/07 01:51:33

Last Close

71.70

25/07 22:30

Market Cap

628.74B

Beta: 0.31

Volume Today

16.42M

Avg: 1.35M

PE Ratio

43.81

PFCF: 52.23

Dividend Yield

0.25%

Payout:37.96%

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other ch...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.20.40.60.812017-08-102019-08-092021-08-042023-08-102025-01-29

    Revenue (Estimate*)

    10B20B30B40B50B60B70B2017-08-102019-08-092021-08-042023-08-102025-01-29

    *Estimate based on analyst consensus